| HIV + DM2+ | HIV + DM2- | Controls with DM2 | Healthy controls | P |
---|
Adiponectin (μg/mL) | 9.79 (8.02–11.56) | 13.83 (10.07–17.06)* | 8.63 (6.96–10.29) | 14.96 (12.80–17.11)* | < 0.001 |
IL-6 (pg/mL) | 2.16 (1.16–3.15) | 1.04 (0.67–1.41)* | 3.89 (0.89–8.66) | 0.91 (0.72–1.11)* | 0.050 |
TNF-alfa (pg/mL) | 3.24 (2.66–3.82) | 2.92 (2.01–3.84) | 4.02 (1.32–6.73) | 2.29 (2.07–2.51) | 0.112 |
sCD14 (ng/mL) | 2333 (1935–2732) | 2218 (1912–2525) | 1461 (1277–1644)* | 1504 (1302–1706)* | < 0.001 |
- Soluble markers presented as mean (95%CI) before log transformation. P-value represent one-way ANOVA analyses after log transformation followed by t-test for comparison between HIV + DM2+ and the 3 control groups when ANOVA test was *p < 0.05 compared to HIV+DM2+
- Abbreviations: HIV + DM2+ People living with HIV with diabetes mellitus type 2, HIV + DM2- People living with HIV without diabetes mellitus type 2, IL-6 Interleukin-6, TNF- α Tumor necrosis factor-alfa, sCD14 Soluble CD14, DM2 Diabetes mellitus type 2